Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
20th Congress of the European College of Neuropsychopharmacology
Therapeutic Strategies for Atypical Antipsychotics: Optimizing Efficacy and Tolerability
Vienna, Austria / October 13-17, 2007
Vienna - The importance of balancing efficacy and tolerability of antipsychotic therapy in patients with schizophrenia was emphasized by researchers here this week. It has been well documented that atypical antipsychotics are equally...
Based on the following article: Williams et al. American Journal on Addictions 2004;13:381-9
Attention-Deficit Hyperactivity Disorder: Assessing the Risks of Treatment Misuse and Abuse
Reviewed by: Samuel Y. Chang, MD, FRCPC Medical Director Addiction Centre Adolescent Program Foothills Medical Centre Calgary, Alberta Clinical Associate Professor Department of Psychiatry University of Calgary Calgary,...
2007 Annual Conference of the Canadian Pain Society
Addressing the Triad of Pain, Psychological Symptoms and Sleep Disturbance
Ottawa, Ontario / May 23-26, 2007
Ottawa - Chronic pain is associated with significant distress and may be accompanied by sleep disturbance and/or psychological symptoms such as depression and anxiety. Concurrent treatment of comorbidities is a crucial element of...
2007 American Psychiatric Association Annual Meeting
Early Intervention, Compliance and Remission in Schizophrenia
San Diego, California / May 19-24, 2007
San Diego - The benefits of early treatment of patients with a first episode of schizophrenia have been clearly demonstrated in several clinical trials. The goal of early treatment is to achieve remission and prevent or delay the onset of...
160th Annual Meeting of the American Psychiatric Association
Long-term Improvements in Adolescents with ADHD
San Diego, California / May 19-24, 2007
Here at the APA annual meeting, investigators presented efficacy, safety and tolerability data of an open-label extension of a prior phase III clinical trial. According to their results, adolescents with attention-deficit hyperactivity...
38th Annual Medical-Scientific Conference of the American Society of Addiction Medicine
Primary Care Management of Opiate Addiction
Miami, Florida / April 26-30, 2007
Miami - Substance abuse and addiction are diseases which pose a worldwide public health threat. Data from the Canadian Community Health Survey suggest that at least 200,000 Canadians have dependency problems related to illicit drugs, while...
Based on the following articles: Behav Brain Res 1998;94:127-52; J Clin Psychiatry 2006;67(suppl 8):32-7
Combining Dopaminergic and Noradrenergic Strategies in ADHD Management
Reviewed by: Robert D. Hunt, MD Center for Attention and Brain Function Nashville, Tennessee As research elucidates more of the mechanisms in the field of attention-deficit/hyperactivity disorder (ADHD), investigators are also learning to...
15th European Congress of Psychiatry
Cardiovascular Risk and Cardiometabolic Risk Factors in Schizophrenia
Madrid, Spain / March 17-21, 2007
Madrid - The life expectancy of patients with schizophrenia is approximately 15 years shorter than that of the general population. More than half the difference is explained by physical illnesses. Individuals with schizophrenia have higher...
26th Annual Conference of the Canadian Academy of Child and Adolescent Psychiatry 2006
CADDRA Survey Results: Tracking ADHD Patient Response
Toronto, Ontario / November 12-14, 2006
Following the reinstatement of the extended-release mixed amphetamine salts (MAS XR) on the Canadian market in August 2005, there are still reactions from physicians and patients alike, according to Canadian child and adolescent...